PGL 0.00% 85.0¢ prospa group limited.

phase iii delays likely to be damaging

  1. 498 Posts.
    Slow uptake on the trial could be a sign of lack of confidence in the drug. With no news for many months, it might be wise to steer clear of the likely decline in sp.
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.